Загрузка...
Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist
The chemokine receptor 4 (CXCR4) is a biomarker that is over-expressed in ductal carcinoma in situ (DCIS). Hence, CXCR4-targeted (molecular) imaging approaches may have diagnostic value in such a challenging, premalignant lesion. The indium labeled CXCR4 peptide-antagonist, (111)In-DTPA-Ac-TZ14011,...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3478110/ https://ncbi.nlm.nih.gov/pubmed/23133805 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|